Medicare Beneficiaries Would Be Able To Share In Rebates From Drugmakers Under Trump’s Plan
President Donald Trump is also proposing to expand Medicare's "catastrophic" drug benefit so that many seniors with very high costs would not face copayments.
The Associated Press:
Trump Proposes Reduction Of Drug Costs Under Medicare
President Donald Trump will propose lowering prescription drug costs for Medicare beneficiaries by allowing them to share in rebates that drug companies pay to insurers and middlemen, an administration official said. A senior administration official outlined the plan Thursday on condition of anonymity ahead of the release of Trump's 2019 budget plan next week. (Alonso-Zaldivar and Perrone, 2/9)
In other pharmaceutical news —
The Wall Street Journal:
Teva Pharmaceutical Shares Plunge After Quarterly Loss And 2018 Outlook Warning
Israel’s Teva Pharmaceutical Industries Ltd. on Thursday said it took a $17 billion charge against the value of its U.S. generics business and posted a $11.6 billion fourth-quarter loss, capping a tumultuous 2017 that saw a management and boardroom shake-up. While the world’s biggest generic drugmaker has struggled for months, the magnitude of the loss and a warning from Chief Executive Kare Schultz that 2018 could prove just as difficult sent the firm’s shares reeling. (Jones, 2/8)
